Pacer Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Pacer Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,039	Closed	-$304K	–	772
2018 Q4	$304K	Buy	20,039 +2,675	+15%	+$51K	0.01%	187
2018 Q3	$347K	Buy	17,364 +13,666	+370%	+$311K	0.01%	928
2018 Q2	$72K	Buy	+3,698	New	+$81.8K	﹤0.01%	1090
2018 Q1	–	Sell	-3,849	Closed	-$51K	–	1162
2017 Q4	$51K	Buy	3,849 +1,032	+37%	+$15.6K	﹤0.01%	1011
2017 Q3	$52K	Sell	2,817 -79	-3%	-$1.47K	﹤0.01%	1107
2017 Q2	$53K	Buy	+2,896	New	+$57.4K	0.01%	1109

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pacer Advisors's AMAG Position: Q1 2019 in Review

Pacer Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 20,039 shares — an estimated $304K sold.

Pacer Advisors first reported a position in AMAG in Q2 2017 and held it in 6 quarters. The position peaked at $347K in Q3 2018. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Pacer Advisors reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Pacer Advisors sold 20,039 AMAG Pharmaceuticals shares in Q1 2019, an estimated $304K.
Pacer Advisors first reported a position in AMAG Pharmaceuticals in Q2 2017 and held it in 6 quarters.
Pacer Advisors's AMAG Pharmaceuticals position peaked at $347K in Q3 2018.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Pacer Advisors's 13F filing for Q1 2019, filed 10 Apr 2019.